.svg){kind=small}
Mar-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the competitive cannabis market of California, Opi-Not has shown varied performance across different categories. Specifically, in the Tincture & Sublingual category, Opi-Not's ranking fluctuated outside the top 30, peaking at a rank of 44 in March 2024 from a low of 52 in January 2024. This movement indicates a struggle to capture a significant market share within this category, despite a slight improvement in rank over the quarter. The sales in December 2023 were notably higher at 1369 units, suggesting a decrease in performance post-holiday season, which could be a point of concern or an area for strategic improvement.
Conversely, Opi-Not's performance in the Topical category within the same state presents a more positive outlook. The brand consistently improved its ranking from 23 in December 2023 to 17 by March 2024, marking its presence within the top 20 brands. This consistent upward movement is a good indicator of growing consumer preference and brand strength in this category. Notably, the sales surged in January 2024 to 8322 units, a significant increase from December 2023. This spike in sales, followed by a gradual decline, suggests a potential seasonal demand or a successful marketing effort that could be replicated in other categories or states to improve overall brand performance.
Competitive Landscape
In the competitive landscape of the topical cannabis category in California, Opi-Not has shown a notable upward trajectory in its market position, despite not breaking into the top 20 until January 2024. From being unranked in December 2023, Opi-Not climbed to the 19th position by January and continued to improve, reaching the 17th rank by March 2024. This rise in rank is particularly impressive considering its initial sales figures were significantly lower than its competitors. For instance, Wild Bill's, which consistently held ranks between 13th and 15th from December to March, started with sales figures over 20 times higher than Opi-Not in December 2023. Similarly, High Gorgeous by Yummi Karma and Quim also showed higher initial sales but experienced fluctuations in their rankings, with Quim notably dropping to the 19th position by March 2024. Cannariginals Emu 420 maintained a steady but lower rank, hovering around 18th place. Opi-Not's growth trajectory, despite its late start and lower initial sales, suggests a strong market acceptance and potential for further rank advancement against its competitors in the topical cannabis market in California.
Notable Products
In Mar-2024, Opi-Not's top product was the CBD:THC 20:1 Sandalwood Spice Nano Lotion, maintaining its first place from February with sales reaching 203 units. Following in second place was the CBD/THC 1:1 Daytime Nano Tincture, which improved from its fourth-place position in February. The CBD/THC 1:1 Nighttime Nano Tincture secured the third spot, showing consistency in its ranking since January. The CBD:THC 1:1 Sandalwood Spice Nano Lotion, previously leading in January, dropped to fourth place in March. These shifts highlight dynamic customer preferences and the competitive nature of product performance within Opi-Not's range.
Top Selling Cannabis Brands
